Results 211 to 220 of about 169,585 (295)

The prevalence of antipsychotic polypharmacy and its associations with violent behaviors among forensic psychiatry patients. [PDF]

BMC Psychiatry
Kaggwa MM, Abaatyo J, Christi P, Lessard E, Bradford J, Chaimowitz GA, Olagunju AT.   +6 more
europepmc   +1 more source

Does faster aspart improve time in range in children with type 1 diabetes with glycaemia close to target on insulin pump therapy?

Diabetic Medicine, EarlyView.
Abstract Aims To evaluate whether faster insulin aspart (FIA) improves time in range (TIR) compared with standard insulin aspart (SIA) in children and adolescents with type 1 diabetes achieving glycaemia close to target treated with continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM).
Kowalczyk‐Korcz Emilia, Dymińska Magdalena, Groele Lidia, Szypowska Agnieszka   +3 more
wiley   +1 more source

Antidepressant Augmentation of Antipsychotic Treatment in Schizophrenia: A Narrative Review. [PDF]

Med Sci Monit
Li W, Gao B, Liu Y, He W, Zha W, Du S, Zeng Y, Zhang Y.   +7 more
europepmc   +1 more source

Clinically significant hypoglycaemia in hospitalised adults: A multicentre study of 1205 episodes in the United Kingdom

Diabetic Medicine, EarlyView.
Abstract Introduction and Objectives Inpatient hypoglycaemia is a serious complication of diabetes therapy, yet real‐world data on clinically significant episodes remain limited. The objectives of this study are (1) to describe the clinical and biochemical characteristics of clinically significant inpatient hypoglycaemia across multiple NHS sites, (2 ...
Charles Page, Mariam Idrissi, Sam Sherratt‐Mayhew, Aashritha Buchipudi, Amanda Ling Jie Yee, Kalyaani Persad, Aqeelah Khatoon, Amrit Rakkar, Amynta Arshad, Alexandra Lubina Solomon, Rajeev Raghavan, Lakshmi Rengarajan, Ahmed Iqbal, Pratik Choudhary, Aspasia Manta, Punith Kempegowda, DEVI Collaboration   +16 more
wiley   +1 more source

Risk of Relapse in Psychotic and Bipolar Disorders After Prenatal Antipsychotic Discontinuation.

JAMA Netw Open
Liu X, Smout S, Mahjani B, Munk-Olsen T, Blæhr EE, Robakis TK, Bergink V.   +6 more
europepmc   +1 more source

Antipsychotics lower peripheral markers of inflammation in drug-naïve early psychosis: a pilot study. [PDF]

Front Psychiatry
Šafářová N, Kolenič M, Tašková I, Čapek V, Fürstová P, Španiel F.   +5 more
europepmc   +1 more source

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström, Henrik Svanström, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Viktor Wintzell, Kristian Hveem, Christian Jonasson, Mads Melbye, Peter Ueda, Björn Pasternak   +10 more
wiley   +1 more source

MicroRNAs in metabolic effects with atypical antipsychotics-a scoping review. [PDF]

Ther Adv Psychopharmacol
Wu WT, Setiawan D, Glatt SJ, Chi JT, Lin PI.   +4 more
europepmc   +1 more source

Iloperidone treatment mitigates the Juvenile Huntington's Disease phenotype possibly via Sigma‐1 Receptor Modulation

The FEBS Journal, EarlyView.
We investigated the potential of iloperidone as an activator of Sigma‐1 receptor (S1R) neuroprotective function in juvenile Huntington's disease (jHD). We tested iloperidone on cortical neurons differentiated from patient‐derived iPSCs, demonstrating that it acts as a S1R agonist, decreasing apoptosis, huntingtin aggregation, and oxidative stress ...
Ersilia Fornetti, Gaia Galluzzi, Mario Frezzini, Cécile Exertier, Vittorio Brufani, Gianni Colotti, Giancarlo Ruocco, Jessica Rosati, Angelo Luigi Vescovi, Daniele Narzi, Ilaria Genovese, Andrea Ilari   +11 more
wiley   +1 more source

Trends in Antipsychotic Drug Use in the United States, 2000-2016. [PDF]

Pharmacy (Basel)
Haddad N, Farhat N, Go J, Chen Y, Gravel CA, Momoli F, Mattison DR, McNair D, Alami A, Krewski D.   +9 more
europepmc   +1 more source